SYNTHESIS, STEREOCHEMISTRY, AND BIOLOGICAL PROPERTIES
OF THE DEPIGMENTING AGENTS, MELANOSTATIN, FELDAMYCIN AND ANALOGS JAN. 1991 Kiyoto Imae, Hajime Kamachi, Haruhiro Yamashita,Takaaki Okita, Satsuki Okuyama, Takashi Tsuno, Tetsuro Yamasaki, Yosuke Sawada, Masaru Ohbayashi, Takayuki Naito and Toshikazu Oki
Bristol-Myers Squibb Research Institute, 2-9-3 Shimo-meguro, Meguro-ku, Tokyo 153, Japan (Received for publication July 14, 1990) Syntheses of melanostatin and feldamycin have been completed from L-serine and L-threonine, respectively, and the configuration of unknown asymmetriccarbons determined. Feldamycinanalogs have also been prepared and the L-tryptophyl analog was the most potent in the depigmentation of Streptomyces bikiniensis and B16 melanomacells.
In the course of screening for melanin biosynthesis inhibitors using Streptomyces bikiniensis NRRL B-1049, BMY-28565and BMY-28566were isolated from Streptomyces calvus No. N924-1 and Streptomyces clavifer No. N924-2, respectivelylj2).
They inhibited melanin synthesis in the growing cells of S. bikiniensis and B16 melanoma, but did not show any inhibitory activity on mushroom tyrosinase.
From structural studies BMY-28565 was identical to feldamycin3 '4) , reported as an antibacterial antibiotic, whereas BMY-28566was revealed to be a new compound and named melanostatin2), which wasdeduced to have the pseudotripeptide structure 1. Two of the three asymmetric centers of 1 were determined to have the 5-configuration, but the stereochemistry of the remaining carbon was still uncertain. The structure of feldamycin (2) has been reported3'4) with no description of the stereochemistry of the four asymmetric carbons in the molecule. Our degradation work indicated that the histidine moiety of 2 has the same 5-configuration as that of 1. However, the stereochemistry of the other three carbons remained unknown (Fig. 1 ). This report describes the total synthesis and stereochemistry of melanostatin and feldamycin, preparation of the analogs and their inhibitory activity on melanin biosynthesis. (1) and Feldamycin (2) The total synthesis of melanostatin has been accomplished from L-serine, according to the procedure shown in Scheme 1. Nakagawa et al.^>) reported that an attempted cyclization of Af,0-ditosyl-L-serine ethyl ester (3, Et ester) to an optically active jV-tosylaziridine ester (4, Et ester) under basic conditions (triethylamine(Et3N) -THF) resulted in elimination of the O-tosyl group to give a dehydroamino ester, although the corresponding TV-trityl ester6) gave the 7V-tritylaziridine derivative. Nakajima et al.7) applied this observation to the preparation of optically active TV-acylaziridine derivatives which were prepared by cyclization of the 7V-trityl derivative followed by detritylation and 7V-acylation. Weconfirmed that the reaction of 3 with Et3N in JAN. 1991 THF resulted in 1,2-elimination to give a dehydroamino ester as reported in the literature5), but in the reaction in MeOH,1,3-elimination of 3 proceeded smoothly to afford the desired N-tosylaziridine ester 4 in good yield, although the reason for this observation could not be explained clearly. The nucleophilic ring opening reaction of 4 with L-histidine gave the a,/?-diamino acid derivative 5 with a small amount of a regio-isomer (6). The desired product 5 was isolated and the A^-tosyl group removed in the usual manner to give 7. The acylation of 7 with Af-methyl-L-phenylalanine active ester followed by deblocking afforded (1) , which was identical with the natural product2) (IR, *H NMR,[a]D and TLC).
Synthesis of Melanostatin
This confirmed that the unknown asymmetric carbon of melanostatin was of the S-configuration.
The synthesis of feldamycin (2) from L-threonine was achieved by a similar sequence. The 7V-tosylaziridine 85) was also obtained by direct cyclization of the corresponding 7V,0-ditosyl ester with Et3N in MeOHand converted to the intermediate 98'9) which retained the configuration of the C-3 asymmetric carbon of L-threonine by a double inversion mechanism10). Protected N-methyl-L-histidine1 1* was coupled with 9 and the acylated product was deblocked to give the pseudotripeptide (2), which was then converted to the corresponding hydrochloride (2-HC1). The [a]D values of the synthetic product (-7.1°) and its HC1 salt (+ll.4°) were nearly identical to those reported for feldamycin (-6.6°-and + 12°)3), respectively. Thus, the structure of feldamycin has been established as
Feldamycin Analogs and Their Inhibition of Melanin Biosynthesis
A variety of feldamycin analogs (10~30) were prepared to characterize the relationship between structure and depigmenting activity. The coupling of 9 with various amino acids was carried out by the active ester method. The products were purified by column chromatography on silica gel and ion exchange resin. The derivatives prepared by this procedure are listed in Table 1 with their depigmenting activity, which was determined by in vitro assays using S. bikiniensis B-1049 and B16 melanoma cells1*. The L-asparaginyl derivative (22) has been reported8 '9'12) as the immunomodulating agent FR900,490, but its depigmenting activity has never been described. As shownin Table 1 , the inhibitory activity on melanin synthesis was not affected to a large extent by the third amino acid residue (R-COin Table 1 ). Little correlation was observed between the activities measured by the two assay methods. The stereochemistry of the amino acid residue (10 vs. ll, 16 vs. 17, 19 vs. 20 and 22 vs. 23) had little effect on the activity of the diastereoisomers. The L-tryptophan analog (15) showed the best activity in both assay systems and was followed by the l-and D-phenylglycine (16 and 17), l-and D-asparagine (22 and 23), and L-tyrosine (13) derivatives.
Experimental IR spectra were measured on an Analect FX-6160 EV spectrometer. *H NMRspectra were recorded on a Varian or Jeol GX-400 (400MHz) spectrometer using TMS or sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) as an internal standard.
[a]D values were recorded on a Jasco DIP-140 digital polarimeter. Mass spectra were obtained with a Jeol JMS-AX505H mass spectrometer. (3)7) (12.82 g, 30 mmol) and Et3N (4. 15 ml, 30.5 mmol) in MeOH(60ml) was heated at reflux for 30 minutes and cooled to room temperature. The resulting mixture was diluted with EtOAc (600ml) and washed with 10% citric acid, 1 m NaHCO3,and brine. The organic extract was dried and concentrated. The residual oil (8.0g) was passed through an alumina column (160g). The eluate with rc-hexane-EtOAc (4: 1 -1 : 1) was concentrated to obtain 3.33g of 4 as an oily product. Yield 43%. IR vmax (film) cm "1 1745, 1590, 1330, 1230, 1160 
Acid (5) and Its Regio Isomer (6) A suspension of4 (3.13g, 12.3mmol) in MeOH(12.5ml) and 1 n NaOH (12.5ml) was stirred under cooling in an ice bath for 1 hour and to the resulting solution were added L-histidine monohydrochloride hydrate (7.74g, 36.9mmol) and NaOH(2.0g, 50mmol). The mixture was heated to reflux for 1 hour and then concentrated to dryness. The residual oil was diluted with water (15 ml) and the solution was adjusted to pH 7.0 by adding 2n H2SO4. The resulting crystalline precipitate was filtered off (1.27g of histidine was recovered) and the filtrate was acidified to pH 4. The acidified solution was adsorbed onto a column of high porous resin Diaion HP-20 (400ml) which was washed with water and eluted with 50% aq MeOH. The desired fractions were combined and concentrated to obtain 4.7 g of yellow solid, which was subjected to column chromatography (Kieselgel 60, 120g (5f)-2-Amino-3-[( 1 5)-l -carboxy-2-(l^-imidazol-4-yl)ethyl]aminopropionic Acid (7) To a stirred mixture of 5 (1.83g, 4.62mmol) in liq ammonia (20ml) was added Na metal (940mg, 40.9matom) in small pieces. The resulting deep blue mixture was stirred for 1 hour at -78°C and then quenched by the addition of NH4C1 (2.55g, 48mmol) . Ammonia was removed on standing under atmospheric pressure for 2hours. The residual solid was dissolved in water (20ml), adjusted to pH 4 by the addition of 1 n HC1 and was passed through an Amberlite IR-120 column (H+ type, 100ml). After being washed with water, the column was eluted with 2.8% NH4OH.The desired fractions were combined, concentrated to dryness, and the residue was lyophilized to afford 1. 
To a stirred solution of7 (100mg, 0.41 mmol) and Et3N (172/xl, 1.24mmol) in 50% aq dioxane (4ml) was added Af-hydroxysuccinimide ester of A^m-BOC-TV-methyl-L-phenylalanine (300 mg, 0.82 mmol). The mixture was stirred overnight, adjusted to pH 5-6 by I n HC1, and concentrated to dryness. The residue was subjected to column chromatography (Kieselgel 60, 30g). The column was eluted with
BuOH-AcOH-water(4: 1 :2) and the desired fraction was concentrated to obtain an oily residue (ca. 600mg), which was diluted with TFA(4ml). The solution was stirred for 2.5 hours at room temperature and evaporated. The residue was diluted with a small amount of water and passed through a column of Amberlite IR-120 (H+ type, ca. 50ml). After washing with water, the column was eluted with 2.8% NH4OH and the desired fractions were combined and concentrated. The residue was subjected to column chromatography (Kieselgel 60, 50g). The column was eluted with BuOH-AcOH-water with ratios of 5 : 1 : 2, 4 : 1 : 2, and 3 : 1 : 2, successively. The desired fractions were combined, concentrated, and the residue was further purified on a column of Kieselgel 60 (10g) eluted with BuOH-AcOH-water (5: 1 :2 and 4: 1 :2). The desired fractions were combined and concentrated. The residue was diluted with a small amount of water and passed through a column of Amberlite IR-120 (20 ml), which was washed with water and eluted with 2.8% NH4OH.The desired fractions were concentrated and lyophilized to obtain 58 mg of 1 as an amorphous powder. Yield 35%. (1)2).
(25' ,3 S)-l -Tosyl-2-methoxycarbonyl-3-methylaziridine (8) A mixture of A^O-ditosyl-L-threonine methyl ester9) (93 g, 0.21 mol) and Et3N (29.3 ml, 0.21 mol) in MeOH(450ml) was refluxed for 1.5 hours and then evaporated to dryness. The residue was diluted with EtOAcand washed with water. The organic extract was dried, concentrated, and the residual oil was diluted with isopropyl ether. The crystalline precipitate was collected by filtration to obtain 37. (2^,3i?)-2-Amino-3-[(1 5' )4 -carboxy-2-( 1 7/-irnidazol-4-yl)ethyl]arriinobutyric Acid (9) A suspension of8 (51.15g, 0.19mol) in MeOH(200ml) and 1 n NaOH (190ml) was stirred at room temperature for 30 minutes and to the resulting solution were added L-histidine monohydrochloride hydrate (145g, 0.69mol) and NaOH (64.75g, 1.62mol) in MeOH(36.5ml) and water (50ml). The mixture was heated to reflux for 2hours and was concentrated to dryness. The residual oil was diluted with water, and pH of the solution was adjusted to 5.0 by adding 2n H2SO4. The resulting crystalline precipitate was collected by filtration, and washed with water and MeOHto obtain 35.0g of the ring-opened product (yield 45%). MP187~190°C (the regio isomer was isolated from the mother liquor).
To a stirred mixture of the above intermediate (34.6 g, 84mmol) in liq NH3(350ml) was added sodium metal (15.9 g, 0.69m atom) in small pieces, and the resulting deep blue mixture was stirred for 40minutes at -78°C. The reaction was quenched by the addition of NH4C1, and NH3 was removed on standing under atmospheric pressure. The residual solid was dissolved in water, adjusted to pH 4 by the addition of2 n H2SO4 and passed through an Amberlite IR-120 column. After being washed with water, the column was eluted with 2.8% NH4OH.The desired fractions were combined and concentrated to dryness and the residue was crystallized from MeOHto afford 6.71 g of9 as a colorless powder. Yield 31%. MP220~225°C. IR vmax (KBr) cm"1 2995, 2850, 1620, 1580. *H NMR (D2O+NaOD) 3 1.13 (3H, d, /=7Hz), 2.6-4.3 (5H, m), 7.06 (1H, s), 7.81 (1H, d, /=1Hz).
To a stirred solution of 9 (319mg, 1.24mmol) and Et3N (455mg, 4.5mmol) in water (4.5ml) was added a solution of N-hydroxysuccinimide ester of AU-bis-BOC-N-methyl-L-histidine (1.0 g, 2.14mmol) in dioxane (9 ml). The mixture was stirred at room temperature overnight and then concentrated to dryness. The residue was dissolved in a small volume of BuOH-H2O-AcOH (4: 1 : 2) and purified on a column of Kieselgel 60 (30g) eluted with the same solvent (500ml). The eluate was fractionated and desired fractions (Nos. 4~10) combined and concentrated to afford 1.35 g of oily residue, which was diluted with TFA(4ml). The resulting solution was left at room temperature for 1 hour and then concentrated to dryness. The residue was dissolved with a small volume of water, concentrated again, and diluted with water (20ml). The solution was passed through a column of Amberlite IR-120 (H+ type, 5ml), and after washing with water, the column was eluted with 1 n NH4OH and the eluate was fractionated. The desired fractions (Nos. 5 and 6) were combined and concentrated to obtain 325 mg of amorphous powder, which was dissolved with BuOH-AcOH-H2O (4: 1 :2), and was subjected to column chromatography on Kieselgel 60 (20g). The column was successively eluted with BuOH-AcOH-H2O(4: 1 :2, 150ml; 3 : 1 :2, 200ml; and 2: 1 :2, 150ml), and collected in 15ml fractions. The desired fractions (Nos. 11~16) were combined and concentrated. The residue was dissolved in a small amount of water and passed through a column of Amberlite IR-120 (H+ type, 5ml). After washing with water, the column was eluted with 1 n Preparation of Feldamycin Hydrochloride (2-HC1) A solution of 2 (30mg, 0.074mmol) in 50% MeOH (0.1ml) was diluted with 4n HC1 in MeOH (0.2ml, 0.8mmol). The solution was added dropwise to stirred acetone (20ml) and the precipitate was collected by filtration, washed with acetone and dried to obtain 31 mg of 2 hydrochloride as a hygroscopic white powder. IR vmax (KBr) cm "1 1687, 1656, 1623, 1556; [a] Preparation of Feldamycin Analogs (10-30) Procedure for preparation of 10-30 in Table 1 is fundamentally the same as that described for feldamycin above. Analytical data of the compounds are shown below. The yield is indicated as isolated yieldfrom8.
L-Phenylalanyl
Analog (10 '1 1653 , 1623 , 1617 , 1516 , 1399 , 1250 1HNMR(D2O) 5 1.04(3H, d,/=7Hz), 2.9-3.4(5H, m), 3.7-4.05 (2H, m),4.28 (1H, d, /=7Hz), 6.90 (2H,m) with 10% fetal calf serum were incubated for 6 days at 37°C. During the incubation, the culture medium was once renewed with fresh mediumcontaining the same compoundsolution. After incubation, cells were counted and solubilized with a solution of 1 n NaOHand 10% DMSO(1 : 1). The amount of melanin synthesized was colorimetrically measured at 470 nm, and the inhibition of melanin synthesis was determined from these ODvalues compared to those of control runs (the vehicle group). The MECvalues are expressed as the concentration showing 50%inhibition.
